Publication | Closed Access
Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome
82
Citations
28
References
2020
Year
In patients with AKI-HRS, response to terlipressin and albumin reduces the need for RRT after LT and reduces the risk of CKD at 1 year after LT.
| Year | Citations | |
|---|---|---|
Page 1
Page 1